financetom
Business
financetom
/
Business
/
TikTok seeks to reassure U.S. employees ahead of Jan. 19 ban deadline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TikTok seeks to reassure U.S. employees ahead of Jan. 19 ban deadline
Jan 14, 2025 7:05 PM

(Reuters) - TikTok plans to keep paying U.S. employees even if the Supreme Court does not overturn a law that would force the sale of the short-video app in the U.S. or ban it, the company's leadership said in an internal memo reviewed by Reuters on Tuesday.

The hugely popular platform is owned by China-based ByteDance and has 7,000 employees in the U.S.

"I cannot emphasize enough that your wellbeing is a top priority and so most importantly, I want to reinforce that as employees in the US, your employment, pay, and benefits are secure, and our offices will remain open, even if this situation hasn't been resolved before the January 19 deadline," the memo to TikTok employees said.Last week, the U.S. Supreme Court seemed inclined to uphold the law, which was passed in April, despite calls from U.S. President-elect Donald Trump and lawmakers to extend the Jan. 19 deadline.

Trump, whose inauguration takes place the day after the law goes into effect, has said he should have time after taking office to pursue a "political resolution" to the issue.

"Our leadership team remains laser focused on planning for various scenarios and continuing to plan the way forward," TikTok said in the memo.

"The bill is not written in a way that impacts the entities through which you are employed, only the US user experience," the company said, adding that it will continue to navigate the situation to protect employees and the more than 170 million TikTok users in the United States.

If the court does not block the law by Sunday, new TikTok downloads on Apple (AAPL.O) or Google (GOOGL.O) app stores would be banned but existing users could continue to access the app for some time. The platform's services would degrade and eventually stop working because other companies would be barred from providing support to TikTok.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Profound Medical Receives U.S. FDA  Clearance for
Profound Medical Receives U.S. FDA Clearance for "Contouring Assistant" AI Module
May 14, 2024
08:18 AM EDT, 05/14/2024 (MT Newswires) -- Profound Medical ( PROF ) said on Tuesday that it received 510(k) clearance from the Food and Drug Administration for the company's second TULSA-AI module, Contouring Assistant, for use with its TULSA-PRO system. Contouring Assistant is a machine learning-based prostate segmentation tool designed to assist in delineating the prostate and target ablation volume....
POET Technologies to Collaborate with Foxconn Interconnect Technology for High-Speed AI Systems
POET Technologies to Collaborate with Foxconn Interconnect Technology for High-Speed AI Systems
May 14, 2024
08:28 AM EDT, 05/14/2024 (MT Newswires) -- POET Technologies ( POET ) said Tuesday that it agreed to collaborate with Foxconn Interconnect Technology (FIT) to develop 800G and 1.6T pluggable optical transceiver modules using POET's optical engines. The company's share price jumped 8.3% to US$2.36 at last look in US pre-market trading. The partnership aims to address growing demand from...
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application
May 14, 2024
08:26 AM EDT, 05/14/2024 (MT Newswires) -- PTC Therapeutics ( PTCT ) said Tuesday the US Food and Drug Administration granted priority review for its biologics license application for gene therapy Upstaza. The application was given a target regulatory action date of Nov. 13, PTC said. Upstaza is a one-time gene replacement therapy for aromatic L-amino acid decarboxylase, or AADC,...
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
May 14, 2024
08:30 AM EDT, 05/14/2024 (MT Newswires) -- Profound Medical ( PROF ) said Tuesday that it received US Food and Drug Administration clearance for its TULSA-AI Contouring Assistant for use with its TULSA-PRO system to treat prostate disease. The medical device company said that TULSA uses pixel-by-pixel precision and sound technology to kill diseased prostate tissue without damaging urinary or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved